G61S (p.Gly61Ser) variant of KRT3 (Keratin, type II cytoskeletal 3)
G61S (p.Gly61Ser) in KRT3 (Keratin, type II cytoskeletal 3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
G61S (p.Gly61Ser) variant details
- p.Gly61Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available